| Conferences \ Circulating Biomarkers World Congress 2017 \ Circulating Biomarkers: Cell-Free Nucleic Acids, Proteins and Rare Circulating Cells \ Agenda \ Dolores Di Vizio |
| Register | Login |
Clinical Potentials for Large Oncosome and Exosome Profiling in Prostate and Breast CancerTuesday, 21 March 2017 at 14:30  Add to Calendar ▼2017-03-21 13:30:002017-03-21 14:30:00Europe/LondonClinical Potentials for Large Oncosome and Exosome Profiling in Prostate and Breast CancerSELECTBIOenquiries@selectbiosciences.comExtracellular vesicles (EVs) are important mediators of intercellular mechanisms as they can shuttle from one cell to another a reservoir of functional molecules (bioactive proteins, nucleic acids and lipids). EVs are highly heterogeneous and differ by size, composition and function. As a common characteristic, they all are surrounded by a lipid bilayer and can act in the proximity of the cell or at distance. Given the abundance of cancer-derived molecules that can be found in each particle, EVs are being recognized as appealing biomarkers of diagnosis and prognosis. Because these molecules are functional, EV profiling has also the potential to identify therapeutic targets in the personalized medicine effort. Our team recently reported that highly metastatic cells undergoing mesenchymal to amoeboid transition export large (1-10 µm diameter) bioactive EVs (large oncosomes) that originate from the shedding of bulky membrane protrusions from the plasma membrane. We have demonstrated that the abundance of large oncosomes in the circulation and in tissues correlates with advanced disease in mouse models and human subjects, and that these vesicles are promising candidates for liquid biopsy approaches through large scale profiling of protein, DNA and mRNA. |
Add to Calendar ▼2017-03-20 00:00:002017-03-21 00:00:00Europe/LondonCirculating Biomarkers: Cell-Free Nucleic Acids, Proteins and Rare Circulating CellsSELECTBIOenquiries@selectbiosciences.com
